ヒト成長ホルモン市場：投与経路、タイプ、流通、用途別-2023-2030年の世界予測

ヒト成長ホルモンの世界市場は、2023年に57億7,493万米ドル、CAGR 8.85%で大きく成長し、2030年には104億6,910万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のヒト成長ホルモン市場を評価するために不可欠です。ビジネス戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーが特定のニーズに基づいて情報に基づいた意思決定を行えるようにします。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.ヒト成長ホルモンの世界市場規模および予測は？

2.予測期間中、世界のヒト成長ホルモン市場を形成するCOVID-19の阻害要因と影響は？

3.ヒト成長ホルモンの世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.ヒト成長ホルモンの世界市場における競争戦略は？

5.ヒト成長ホルモンの世界市場における技術動向と規制の枠組みは？

6.ヒト成長ホルモンの世界市場における主要ベンダーの市場シェアは？

7.ヒト成長ホルモンの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ホルモン疾患に関連する症例が急増
    • 償還ポリシーの増加
    • 成長ホルモン欠乏症の増加
  • 抑制要因
    • ヒト成長ホルモンの治療手順に関連する費用は高額です
  • 機会
    • ヒト成長ホルモンの製品発売数の増加
    • 公的部門だけでなく民間部門からも研究開発資金が急増
  • 課題
    • ヒト成長ホルモン療法の人体への悪影響
• 市場動向
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ

第6章 ヒト成長ホルモン市場：投与経路別

• 筋肉内
• 静脈内
• オーラル
• 皮下

第7章 ヒト成長ホルモン市場：タイプ別

• アミノ酸誘導体
• ペプチドホルモン
• ステロイドホルモン

第8章 ヒト成長ホルモン市場配信別

• 病院薬局
• オンライン薬局
• 小売薬局

第9章 ヒト成長ホルモン市場：用途別

• 成長ホルモン欠乏症
• プラダーウィリ症候群
• ターナー症候群

第10章 南北アメリカのヒト成長ホルモン市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のヒト成長ホルモン市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのヒト成長ホルモン市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別

第14章 掲載企業一覧

第15章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. HUMAN GROWTH HORMONE MARKET RESEARCH PROCESS
• FIGURE 2. HUMAN GROWTH HORMONE MARKET SIZE, 2022 VS 2030
• FIGURE 3. HUMAN GROWTH HORMONE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2030 (%)
• FIGURE 5. HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
• FIGURE 6. HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2022 VS 2030 (%)
• FIGURE 7. HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 8. HUMAN GROWTH HORMONE MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 9. HUMAN GROWTH HORMONE MARKET DYNAMICS
• FIGURE 10. HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES HUMAN GROWTH HORMONE MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 18. HUMAN GROWTH HORMONE MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 19. HUMAN GROWTH HORMONE MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. HUMAN GROWTH HORMONE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. HUMAN GROWTH HORMONE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 5. HUMAN GROWTH HORMONE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. HUMAN GROWTH HORMONE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. HUMAN GROWTH HORMONE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. HUMAN GROWTH HORMONE MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 10. HUMAN GROWTH HORMONE MARKET SIZE, BY AMINO ACID DERIVATIVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. HUMAN GROWTH HORMONE MARKET SIZE, BY PEPTIDE HORMONES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. HUMAN GROWTH HORMONE MARKET SIZE, BY STEROID HORMONES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 14. HUMAN GROWTH HORMONE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. HUMAN GROWTH HORMONE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. HUMAN GROWTH HORMONE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 18. HUMAN GROWTH HORMONE MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. HUMAN GROWTH HORMONE MARKET SIZE, BY PRADER-WILLI SYNDROME, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. HUMAN GROWTH HORMONE MARKET SIZE, BY TURNER SYNDROME, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. CANADA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 35. CANADA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. CANADA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 37. CANADA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES HUMAN GROWTH HORMONE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. CHINA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 57. CHINA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. CHINA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 59. CHINA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. INDIA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 61. INDIA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. INDIA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 63. INDIA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. INDONESIA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. JAPAN HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. MALAYSIA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. PHILIPPINES HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. SINGAPORE HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. SOUTH KOREA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. TAIWAN HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. THAILAND HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. VIETNAM HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. EUROPE, MIDDLE EAST & AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. DENMARK HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. EGYPT HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. FINLAND HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. FRANCE HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. GERMANY HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. ISRAEL HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. ITALY HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 130. ITALY HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 131. ITALY HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 132. ITALY HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. NETHERLANDS HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. NIGERIA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. NORWAY HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. POLAND HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 146. POLAND HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 147. POLAND HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 148. POLAND HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. QATAR HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 150. QATAR HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 151. QATAR HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 152. QATAR HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. RUSSIA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 157. SAUDI ARABIA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 161. SOUTH AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 165. SPAIN HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. SWEDEN HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 173. SWITZERLAND HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 177. TURKEY HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. UNITED ARAB EMIRATES HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 185. UNITED KINGDOM HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 189. HUMAN GROWTH HORMONE MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 190. HUMAN GROWTH HORMONE MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 191. HUMAN GROWTH HORMONE MARKET LICENSE & PRICING

The Global Human Growth Hormone Market is forecasted to grow significantly, with a projected USD 5,774.93 million in 2023 at a CAGR of 8.85% and expected to reach a staggering USD 10,469.10 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Human Growth Hormone Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Human Growth Hormone Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Route of Administration, market is studied across Intramuscular, Intravenous, Oral, and Subcutaneous. The Oral is projected to witness significant market share during forecast period.

Based on Type, market is studied across Amino Acid Derivatives, Peptide Hormones, and Steroid Hormones. The Amino Acid Derivatives is projected to witness significant market share during forecast period.

Based on Distribution, market is studied across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy. The Retail Pharmacy is projected to witness significant market share during forecast period.

Based on Application, market is studied across Growth Hormone Deficiency, Prader-Willi Syndrome, and Turner Syndrome. The Turner Syndrome is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Human Growth Hormone Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Human Growth Hormone Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Human Growth Hormone Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Human Growth Hormone Market?

4. What is the competitive strategic window for opportunities in the Global Human Growth Hormone Market?

5. What are the technology trends and regulatory frameworks in the Global Human Growth Hormone Market?

6. What is the market share of the leading vendors in the Global Human Growth Hormone Market?

7. What modes and strategic moves are considered suitable for entering the Global Human Growth Hormone Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Human Growth Hormone Market, by Route of Administration, 2022 vs 2030
• 4.3. Human Growth Hormone Market, by Type, 2022 vs 2030
• 4.4. Human Growth Hormone Market, by Distribution, 2022 vs 2030
• 4.5. Human Growth Hormone Market, by Application, 2022 vs 2030
• 4.6. Human Growth Hormone Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Surge in the cases related to the hormonal disorders
    • 5.1.1.2. Increase in the reimbursement policies
    • 5.1.1.3. Growing growth hormone deficiency disorders
  • 5.1.2. Restraints
    • 5.1.2.1. Cost related to human growth hormone therapies procedures is high
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing number of product launches of the human growth hormone
    • 5.1.3.2. Surge in research and development fundings from the private as well as public sector
  • 5.1.4. Challenges
    • 5.1.4.1. Adverse impact of human growth hormone therapies on human bodies
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Human Growth Hormone Market, by Route of Administration

• 6.1. Introduction
• 6.2. Intramuscular
• 6.3. Intravenous
• 6.4. Oral
• 6.5. Subcutaneous

7. Human Growth Hormone Market, by Type

• 7.1. Introduction
• 7.2. Amino Acid Derivatives
• 7.3. Peptide Hormones
• 7.4. Steroid Hormones

8. Human Growth Hormone Market, by Distribution

• 8.1. Introduction
• 8.2. Hospital Pharmacy
• 8.3. Online Pharmacy
• 8.4. Retail Pharmacy

9. Human Growth Hormone Market, by Application

• 9.1. Introduction
• 9.2. Growth Hormone Deficiency
• 9.3. Prader-Willi Syndrome
• 9.4. Turner Syndrome

10. Americas Human Growth Hormone Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Human Growth Hormone Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Human Growth Hormone Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. FPNV Positioning Matrix
• 13.2. Market Share Analysis, By Key Player
• 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

• 15.1. Discussion Guide
• 15.2. License & Pricing